Table 2.
Proportion of high, moderate, low, and very low quality of evidence and of strength of recommendation, overall and for HAP/VAP treatment, diagnosis, and prevention. Data shown as number (%)
| Overall | Treatment | Diagnosis | Prevention | |
|---|---|---|---|---|
| Quality of evidence | ||||
| Total | 80 | 45 | 9 | 26 |
| High | 7 (8.7) | 0 | 0 | 7 (26.9) |
| Moderate | 24 (30) | 9 (20) | 2 (22.2) | 13 (50) |
| Low | 29 (36.3) | 18 (40) | 5 (55.6) | 6 (23.1) |
| Very low | 20 (25) | 18 (40) | 2 (22.2) | 0 |
| Strength of recommendations | ||||
| Total | 54 | 45 | 9 | NA |
| Strong | 24 (44.4) | 21 (46.7) | 3 (33.3) | |
| Weak | 30 (55.6) | 24 (53.3) | 6 (66.7) | |